Sheng Yun

439 citations
16 papers · 336 indexed · h-index 11
Topics
Mesenchymal stem cell research (3 papers)Drug Transport and Resistance Mechanisms (3 papers)Tissue Engineering and Regenerative Medicine (2 papers)

In The Last Decade

Sheng Yun

16 papers receiving 331 citations

Peers

Sheng Yun
Comparison fields: 5 of 61
  • Immunology 199
  • Molecular Biology 75
  • Surgery 64
  • Epidemiology 41
  • Rheumatology 36
Replace Aihiro Yamamoto with:
Aihiro Yamamoto Japan
Guocan Yang China
Yan Dai China
Muhammad Yassin Israel
Ekaterina Zezina Germany
Mathias Drach Austria
Louise Tzung-Harn Hsieh Germany
Kelly M. England United States
Aitana Braza‐Boïls Spain
Sheng Yun relative to Aihiro Yamamoto Japan Aihiro Yamamoto's profile →
Citations per field
00.5×3.3×
Aihiro Yamamoto · 1×
Citations per year

Countries citing papers authored by Sheng Yun

Since Specialization
Citations

This map shows the geographic impact of Sheng Yun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Yun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Yun more than expected).

Fields of papers citing papers by Sheng Yun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Yun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Yun. The network helps show where Sheng Yun may publish in the future.

Co-authorship network of co-authors of Sheng Yun

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Yun. A scholar is included among the top collaborators of Sheng Yun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Yun. Sheng Yun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 15
2 1
3 8
4 17
5 14
6 12
7 10
8 1
9 3
10 16
11
Human umbilical cord mesenchymal stromal cells suppress MHC class II expression on rat vascular endothelium and prolong survival time of cardiac allograft.
14
12 23
13 38
14 33
15 127
16 4

About Sheng Yun

Sheng Yun is a scholar working on Immunology, Genetics and Biochemistry, having authored 16 papers that have together received 336 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Tissue Engineering and Regenerative Medicine (2 papers). The work is most often cited by research in Immunology (199 citations), Hematology (30 citations) and Rheumatology (36 citations). Sheng Yun has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Marina Botto, Joseph J. Boyle, Dorian O. Haskard, Vinay K. Bhatia, G. Martin Benson, David C. Grimsditch, Hanyu Yang, Xiaodong Liu, Liang Zhu and Ying Qiu. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, American Journal Of Pathology and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026